Leukocyte trafficking in experimental autoimmune uveitis: Breakdown of blood-retinal barrier and upregulation of cellular adhesion molecules

Investigative Ophthalmology and Visual Science

Volumn 44, Issue 1, 2003, Pages 226-234

  Xu, Heping ^a   Forrester, John V ^a   Liversidge, Janet ^a   Crane, Isabel J ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCEIN; CD31 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EVANS BLUE; INTERCELLULAR ADHESION MOLECULE 1; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; CELL ADHESION; CONTROLLED STUDY; FEMALE; FLUORESCENCE; HUMAN; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; INGUINAL LYMPH NODE; LEUKOCYTE MIGRATION; LYMPHOCYTE; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PATHOGENESIS; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA VEIN; TIME SERIES ANALYSIS; UVEITIS;

ANIMALS; AUTOIMMUNE DISEASES; BLOOD-RETINAL BARRIER; CAPILLARY PERMEABILITY; CELL ADHESION; CELL ADHESION MOLECULES; ENDOTHELIUM, VASCULAR; EYE PROTEINS; FEMALE; FLUORESCEINS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FLUORESCENT DYES; LEUKOCYTES; MICE; MICROSCOPY, CONFOCAL; OVALBUMIN; RETINAL VESSELS; RETINOL-BINDING PROTEINS; UP-REGULATION; UVEITIS, POSTERIOR;

EID: 0037250362     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.01-1202     Document Type: Article

References (35)

1. Forrester JV, Liversidge J, Dua HS, Dick A, Harper F, McMenamin PG. Experimental autoimmune uveoretinitis: a model system for immunointervention: a review. Curr Eye Res. 1992;11:33-40.
2. Dua HS, Hossain P, Brown PA, et al. Structure-function studies of S-antigen: use of proteases to reveal a dominant uveitogenic site. Autoimmunity. 1991;10:153-163.
3. Greenwood J, Howes R, Lightman S. The blood-retinal barrier in experimental autoimmune uveoretinitis: leukocyte interactions and functional damage. Lab Invest. 1994;70:39-52.
4. Lightman S, Greenwood J. Effect of lymphocytic infiltration on the blood-retinal barrier in experimental autoimmune uveoretinitis. Clin Exp Immunol. 1992;88:473-477.
5. Luna JD, Chan CC, Derevjanik NL, et al. Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: comparison with vascular endothelial growth factor, tumor necrosis factor alpha, and interleukin-1beta-mediated breakdown. J Neurosci Res. 1997;49:268-280.
6. Kulidjian AA, Inman R, Issekutz TB. Rodent models of lymphocyte migration. Semin Immunol. 1999;11:85-93.
7. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994;84:2068-2101.
8. Muller WA, Randolph GJ. Migration of leukocytes across endothelium and beyond: molecules involved in the transmigration and fate of monocytes. J Leukoc Biol. 1999;66:698-704.
9. Muller WA. The role of PECAM-1 (CD31) in leukocyte emigration: studies in vitro and in vivo. J Leukoc Biol. 1995;57:523-528.
10. Madri JA, Graesser D. Cell migration in the immune system: the evolving inter-related roles of adhesion molecules and proteinases. Dev Immunol. 2000;7:103-116.
11. Chan-Ling T, Tout S, Hollander H, Stone J. Vascular changes and their mechanisms in the feline model of retinopathy of prematurity. Invest Ophthalmol Vis Sci. 1992;33:2128-2147.
12. Silver PB, Chan CC, Wiggert B, Caspi RR. The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10.A mice, develop EAU and Th1 responses to IRBP without pertussis treatment. Invest Ophthalmol Vis Sci. 1999;40:2898-2905.
13. Chan-Ling T. Glial, vascular, and neuronal cytogenesis in whole-mounted cat retina. Microsc Res Techn. 1997;36:1-16.
14. Xu HP, Manivannan A, Daniels G, et al. Evaluation of leukocyte dynamics in mouse retinal circulation with scanning laser ophthalmoscopy (video report). Br J Ophthalmol. Available at: http://bjo.bmjjournals.com/misc/eyemov.shtml/Accessed July 2001.
15. Abbitt KB, Rainger GE, Nash GB. Effects of fluorescent dyes on selectin and integrin-mediated stages of adhesion and migration of flowing leukocytes. J Immunol Methods. 2000;239:109-119.
16. Stockton BM, Cheng G, Manjunath N, Ardman B, von Andrian UH. Negative regulation of T cell homing by CD43. Immunity. 1998;8:373-381.
17. Stein JV, Rot A, Luo Y, et al. The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function-associated antigen 1-mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial venules. J Exp Med. 2000;191:61-76.
18. Dick AD, Kreutzer B, Laliotou B, Forrester JV. Phenotypic analysis of retinal leukocyte infiltration during combined cyclosporin A and nasal antigen administration of retinal antigens: delay and inhibition of macrophage and granulocyte infiltration. Ocul Immunol Inflamm. 1997;5:129-140.
19. Sugiyama K, Komada Y, Deguchi T, et al. CD3-mediated T cell activation is inhibited by anti-CD44 monoclonal antibodies directed to the hyaluronan-binding region. Immunol Invest. 1999;28:185-200.
20. Chan-Ling T, Neill AL, Hunt NH. Early microvascular changes in murine cerebral malaria detected in retinal wholemounts. Am J Pathol. 1992;140:1121-1130.
21. Lin WL, Essner E, Shichi H. Breakdown of the blood-retinal barrier in S-antigen-induced uveoretinitis in rats. Graefes Arch Clin Exp Ophthalmol. 1991;229:457-463.
22. Bamforth SD, Lightman S, Greenwood J. The effect of TNF-alpha and IL-6 on the permeability of the rat blood-retinal barrier in vivo. Acta Neuropathol (Berl). 1996;91:624-632.
23. Bamforth SD, Lightman SL, Greenwood J. Interleukin-1 beta-induced disruption of the retinal vascular barrier of the central nervous system is mediated through leukocyte recruitment and histamine. Am J Pathol. 1997;150:329-340.
24. Claudio L, Martiney JA, Brosnan CF. Ultrastructural studies of the blood-retina barrier after exposure to interleukin-1 beta or tumor necrosis factor-alpha. Lab Invest. 1994;70:850-861.
25. Jiang HR, Taylor N, Duncan L, Dick AD, Forrester JV. Total dose and frequency of administration critically affect success of nasal mucosal tolerance induction. Br J Ophthalmol. 2001;85:739-744.
26. Carmo A, Cunha-Vaz JG, Carvalho AP, Lopes MC. Nitric oxide synthase activity in retinas from non-insulin-dependent diabetic Goto-Kakizaki rats: correlation with blood-retinal barrier permeability. Nitric Oxide. 2000;4:590-596.
27. Prendergast RA, Iliff CE, Coskuncan NM, et al. T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci. 1998;39:754-762.
28. Hu P, Pollard JD, Chan-Ling T. Breakdown of the blood-retinal barrier induced by activated T cells of nonneural specificity. Am J Pathol. 2000;156:1139-1149.
29. Wang Y, Calder VL, Lightman SL, Greenwood J. Antigen presentation by rat brain and retinal endothelial cells. J Neuroimmunol. 1995;61:231-239.
30. Crane IJ, McKillop-Smith S, Wallace CA, Lamont GR, Forrester JV. Expression of the chemokines MIP-1α, MCP-1, and RANTES in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci. 2001;42:1547-1552.
31. Crane IJ, Wallace CA, McKillop-Smith S, Forrester JV. Control of chemokine production at the blood-retina barrier. Immunology. 2000;101:426-433.
32. Whitcup SM, DeBarge LR, Caspi RR, Harning R, Nussenblatt RB, Chan CC. Monoclonal antibodies against ICAM-1 (CD54) and LFA-1 (CD11a/CD18) inhibit experimental autoimmune uveitis. Clin Immunol Immunopathol. 1993;67:143-150.
33. Uchio E, Kijima M, Tanaka S, Ohno S. Suppression of experimental uveitis with monoclonal antibodies to ICAM-1 and LFA-1. Invest Ophthalmol Vis Sci. 1994;35:2626-2631.
34. Bargatze RF, Jutila MA, Butcher EC. Distinct roles of L-selectin and integrins alpha 4 beta 7 and LFA-1 in lymphocyte homing to Peyer's patch-HEV in situ: the multistep model confirmed and refined. Immunity. 1995;3:99-108.
35. DeLisser HM, Newman PJ, Albelda SM. Molecular and functional aspects of PECAM-1/CD31. Immunol Today. 1994;15:490-495.